Flucloxacillin Sodium
Brand Formulations & Prices
207 brands sorted by unit price
Fluxicap
Clox-F
Flac
Floxason
Flxzen
Uflu
Sofa
Ancoc
Faxilin
Flubex
Flucillin
Flucloxi
Fluking
Flunid
Flupen
Flustaph
Flustar
Inclox
Isoclox
Monaclox-F
Stafoxin
Stapkil
Flucopen
Flox
Flubiotic
Halopen
Orgaflu
Fluxin
Sinaflox
Cloxafu
Flutam
Flutec
Flucloxin
Flux
Silox
Eflucin
Staflu
Floxabac
Floxapen
Flukin
Revistar
Skilox
Doribac
Flutam
Luf
Flu-K
Flox R
G-Flucloxacillin
S-Fluclox
A-Flox
Flubac
Flucin
Fluclox
Flxzen
Phylopen
Ancoc
Bdflox
Belox
Clox-F
Debac
Dolopen
Faxilin
Flac
Floxason-DS
Fluc
Flucil
Flucillin
Flucloxi
Flumark
Flustaph
Flustar
Flutec-DS
Fluxicap
Inclox
Isoflu
Monaclox-F
Stafoxin
Stapkil
Syflu
Uflu
Flucopen
Orgaflu
Fluxin
Silox
Flubiotic
Revistar
Eflucin
Cloxafu
Surgeflox
Flox
Adflox
Cloxakil
Floxabac
Flubex
Flubion
Flucloxin
Flumed
Flunid
Halopen
Murein
S-Fluclox
Sinaflox
Staphylox-500
Flucocin
Flurif
Doribac
Flu-K
Enoclox
Isoclox
Staflu
Flukin
Fluking
Fucil
Skilox
Softapen
Topflu
E-Flu
Flupen
Flux
Flox R
Luf
A-Flox
Flubac
Fluclox
Phylopen DS
Flucin
G-Flucloxacillin
Flac
Fluking
G-Flucloxacillin
Stapkil
Fluxin
Flustaph
Ancoc
Bdflox
Clox-F
Dolopen
E-Flu
Enoclox
Faxilin
Floxason
Flu-K
Flubex
Fluc
Flucil
Flucillin
Fluclox
Flumark
Flumed
Flustar
Flutec
Fluxi
Flxzen
Isoflu
Sofa
Stafoxin
Doribac
Silox
Flucopen
Revistar
Flox
Orgaflu
Flucloxi
Flunid
Syflu
Flucin
Floxapen
Eflucin
Flox R
Flucloxin
Flux
Fucil
Halopen
Isoclox
Monaclox-F
Sinaflox
Skilox
Staflu
Flukin
Softapen
Topflu
Staphylox
A-Flox
Luf
Phylopen
Flubac
Fluclox
Flupen
Flux
Clox-F DS
Flubex DS
Flucin DS
Flutam DS
Flubac DS
Flux DS
Staflu DS
Phylopen Forte
Fluclox DS
Eflucin
Eflucin
Flucloxin
A-Flox
Phylopen
Floxabac
Flux
Dolopen
Fluclox
📖 Official Clinical Monograph
DGDA Approved Prescribing GuidelinesA-Flox is indicated for the treatment of infections due to Gram-positive organisms, including infections caused by penicillinase producing staphylococci. These indications include:
Skin and soft tissue infections: Boils, abscess, carbuncles, infected skin conditions (e.g. ulcer, eczema, acne, furunculosis, cellulitis, infected wounds, infected burns, otitis media and externa, impetigo).
... Read more
A-Flox is indicated for the treatment of infections due to Gram-positive organisms, including infections caused by penicillinase producing staphylococci. These indications include:
Skin and soft tissue infections: Boils, abscess, carbuncles, infected skin conditions (e.g. ulcer, eczema, acne, furunculosis, cellulitis, infected wounds, infected burns, otitis media and externa, impetigo).
Respiratory tract infections: Pneumonia, lung abscess, empyema, sinusitis, pharyngitis, tonsillitis, quinsy.
It is also used for the treatment of other infections i.e. osteomyelitis, enteritis, endocarditis, urinary tract infection, meningitis, septicaemia caused by A-Flox-sensitive organisms.
As a prophylactic agent, it is used during major surgical procedures where appropriate; for example, cardiothoracic and orthopedic surgery.
Flucloxacillin is contraindicated in penicillin hypersensitive patients.
There have been some common side effects of gastrointestinal tract such as nausea, vomiting, diarrhoea, dyspepsia and other minor gastrointestinal disturbances. Besides these rashes, urticaria, purpura, fever, interstitial nephritis, hepatitis and cholestatic jaundice have been reported.
A-Flox should be used with caution in patients with evidence of hepatic dysfunction. Caution should also be exercised in the treatment of patients with an allergic diathesis.
Flucloxacillin is active against Gram-positive organisms including penicillinase producing strains. It has little activity against Gram-negative bacilli. Flucloxacillin acts by inhibiting the formation of cell wall of bacteria. Flucloxacillin is isoxazolyl penicillin which combined the properties of resistance to hydrolysis by penicillinase, gastric acid stability and activity against gram-positive bacteria. Flucloxacillin is a bactericidal antibiotic that is particularly useful against penicillinase-producing staphylococci. Flucloxacillin kills bacterial cellwall, thus interfering with peptidoglycan synthesis. Peptidoglycan is a heteropolymeric structure that provides the cell wall with its mechanical stability. The final stage of peptidoglycan synthesis involves the completion of the cross-linking with the terminal glycine residue of the pentaglycin bridge linking to the fourth residue of the pentapeptide (D-alanine). The transpeptidase enzyme that performs this step is inhibited by Flucloxacillin. As a result the bacterial cellwall is weakened, the cell swells and then ruptures. Flucloxacillin resists the action of bacterial penicillinase probably because of the steric hindrance induced by the acyl side chain which prevents the opening of the β- lactam ring.